Clinical Trial

To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects

Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized withdrawal, double-blind, parallel, placebo-controlled design clinical trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets to evaluate the long-term efficacy and safety in the treatment of Chinese patients with depression.
Trial Details
NCT Number NCT07371065
Lead Sponsor Luye Pharma Group Ltd.
Conditions Major Depressive Disorder
Enrollment 98 participants
Start Date 2025-10-28
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-27